2,378
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Performance of a validated spontaneous preterm delivery predictor in South Asian and Sub-Saharan African women: a nested case control study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, , , , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 8878-8886 | Received 01 Sep 2021, Accepted 09 Nov 2021, Published online: 30 Nov 2021

References

  • Blencowe H, Cousens S, Chou D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10(Suppl 1):S2.
  • Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21(2):74–79.
  • Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385(9966):430–440.
  • March of Dimes, PMNCH, Save the Children, WHO. Born too soon: the global action report on preterm birth. In: Howson C, Kinney M, Lawn J, editors. Geneva: World Health Organization; 2012.
  • Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet. 2008;371(9608):261–269.
  • Hovi P, Andersson S, Eriksson JG, et al. Glucose regulation in young adults with very low birth weight. N Engl J Med. 2007;356(20):2053–2063.
  • Rotteveel J, van Weissenbruch MM, Twisk JW, et al. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics. 2008;122(2):313–321.
  • Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016;21(2):68–73.
  • Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379(9832):2162–2172.
  • Conde-Agudelo A, Papageorghiou AT, Kennedy SH, et al. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG. 2011;118(9):1042–1054.
  • Kacerovsky M, Lenco J, Musilova I, et al. Proteomic biomarkers for spontaneous preterm birth: a systematic review of the literature. Reprod Sci. 2014;21(3):283–295.
  • Saade GR, Boggess KA, Sullivan SA, et al. Development and validation of a spontaneous preterm delivery predictor in asymptomatic women. Am J Obstet Gynecol. 2016;214(5):633.e1–633–e24.
  • Baqui AH, Khanam R, Rahman MS, et al. Understanding biological mechanisms underlying adverse birth outcomes in developing countries: protocol for a prospective cohort (AMANHI bio-banking) study. J Glob Health. 2017;7(2):021202.
  • Markenson GR, Saade GR, Laurent LC, et al. Performance of a proteomic preterm delivery predictor in a large independent prospective cohort. Am J Obstetrics Gynecol MFM. 2020;2(3):100140.
  • Bradford C, Severinsen R, Pugmire T, et al. Analytical validation of protein biomarkers for risk of spontaneous preterm birth. Clin Mass Spectrom. 2017;3:25–38.
  • Rich B. table1: tables of Descriptive Statistics in HTML. R package version 1.2. 2020.
  • Robinson L. demoGraphic: Providing Demographic Table with the P-Value, Standardized Mean Difference Value. R package version 0.1.0; 2019.
  • Leeper T. margins: Marginal Effects for Model Objects; 2021.
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845.
  • van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Soft. 2011;45(3):1–67.
  • Badsha MB, Fu AQ. Learning causal biological networks with the principle of mendelian randomization. Front Genet. 2019;10(460):460.
  • Badsha MB, Martin EA, Fu AQ. MRPC: An R package for accurate inference of causal graphs. 2021.
  • R Core Team, R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021.
  • Boniface JJ, Burchard J, Saade GR. Effects of selective exclusion of patients on preterm birth test performance. Obstet Gynecol. 2019;134(6):1333–1338.
  • Xargay-Torrent S, Carreras-Badosa G, Borrat-Padrosa S, et al. Circulating sex hormone binding globulin: an integrating biomarker for an adverse cardio-metabolic profile in obese pregnant women. PLOS One. 2018;13(10):e0205592.
  • Glass HC, Costarino AT, Stayer SA, et al. Outcomes for extremely premature infants. Anesth Analg. 2015;120(6):1337–1351.
  • Saad-Haddad G, DeJong J, Terreri N, et al. Patterns and determinants of antenatal care utilization: analysis of national survey data in seven countdown countries. J Glob Health. 2016;6(1):010404–010404.
  • Agha S, Tappis H. The timing of antenatal care initiation and the content of care in Sindh, Pakistan. BMC Pregnancy Childbirth. 2016;16(1):190.
  • Jiwani SS, Amouzou-Aguirre A, Carvajal L, et al. Timing and number of antenatal care contacts in low and middle-income countries: analysis in the countdown to 2030 priority countries. J Glob Health. 2020;10(1):010502.
  • Yu CK, Papageorghiou AT, Bindra R, et al. Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia. J Matern Fetal Neonatal Med. 2004;16(3):158–162.
  • Simo R, Saez-Lopez C, Barbosa-Desongles A, et al. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol Metab. 2015;26(7):376–383.
  • Forbes K, Westwood M. Maternal growth factor regulation of human placental development and fetal growth. J Endocrinol. 2010;207(1):1–16.
  • Giudice LC, Conover CA, Bale L, et al. Identification and regulation of the IGFBP-4 protease and its physiological inhibitor in human trophoblasts and endometrial stroma: evidence for paracrine regulation of IGF-II bioavailability in the placental bed during human implantation. J Clin Endocrinol Metab. 2002;87(5):2359–2366.
  • Qiu Q, Bell M, Lu X, et al. Significance of IGFBP-4 in the development of fetal growth restriction. J Clin Endocrinol Metab. 2012;97(8):E1429–39.
  • Cheifetz S, Bellón T, Calés C, et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem. 1992;267(27):19027–19030.
  • Gregory AL, Xu G, Sotov V, et al. Review: the enigmatic role of endoglin in the placenta. Placenta. 2014;35 Suppl (Suppl):S93–S9.
  • Duff SE, Li C, Garland JM, et al. CD105 is important for angiogenesis: evidence and potential applications. Faseb J. 2003;17(9):984–992.
  • Gougos A, St Jacques S, Greaves A, et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol. 1992;4(1):83–92.
  • Caniggia I, Taylor CV, Ritchie JWK, et al. Endoglin regulates trophoblast differentiation along the invasive pathway in human placental villous explants. Endocrinology. 1997;138(11):4977–4988.
  • Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, et al. Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2021;258:366–381.
  • Jeyabalan A, McGonigal S, Gilmour C, et al. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta. 2008;29(6):555–563.
  • Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
  • Foidart JM, Munaut C, Chantraine F, et al. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia. Ultrasound Obstet Gynecol. 2010;35(6):680–687.
  • Chaiworapongsa T, Romero R, Whitten AE, et al. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. J Matern Fetal Neonatal Med. 2016;29(8):1214–1228.
  • Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21(1):9–23.
  • Conroy AL, McDonald CR, Gamble JL, et al. Altered angiogenesis as a common mechanism underlying preterm birth, small for gestational age, and stillbirth in women living with HIV. Am J Obstet Gynecol. 2017;217(6):684 e1–684 e17.
  • Chaiworapongsa T, Romero R, Tarca A, et al. A subset of patients destined to develop spontaneous preterm labor has an abnormal angiogenic/anti-angiogenic profile in maternal plasma: evidence in support of pathophysiologic heterogeneity of preterm labor derived from a longitudinal study. J Matern Fetal Neonatal Med. 2009;22(12):1122–1139.
  • Kim SK, Romero R, Savasan ZA, et al. Endoglin in amniotic fluid as a risk factor for the subsequent development of bronchopulmonary dysplasia. Am J Reprod Immunol. 2013;69(2):105–123.
  • Al-Chalabi M, Bass AN, Alsalman I. Physiology, prolactin treasure island., FL: StatPearls Publishing. [cited 2020 Jul 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507829/
  • Soares MJ. The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod Biol Endocrinol. 2004;2(1):51.
  • Bachelot A, Binart N. Reproductive role of prolactin. Reproduction. 2007;133(2):361–369.
  • Lopez-Vicchi F, Ladyman SR, Ornstein AM, et al. Chronic high prolactin levels impact on gene expression at discrete hypothalamic nuclei involved in food intake. Faseb J. 2020;34(3):3902–3914.
  • Struman I, Bentzien F, Lee H, et al. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA. 1999;96(4):1246–1251.
  • Leaños-Miranda A, Campos-Galicia I, Ramírez-Valenzuela KL, et al. Circulating angiogenic factors and urinary prolactin as predictors of adverse outcomes in women with preeclampsia. Hypertension. 2013;61(5):1118–1125.
  • O'Brien JM, Peeler GH, Pitts DW, et al. Cervicovaginal prolactin: a marker for spontaneous preterm delivery. Am J Obstet Gynecol. 1994;171(4):1107–1111.
  • Clemmensen I, Petersen LC, Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem. 1986;156(2):327–333.
  • Kluft C, Los P, Clemmensen I. Calcium-dependent binding of tetranectin to fibrin. Thromb Res. 1989;55(2):233–238.
  • Hogdall CK, Soletormos G, Nielsen D, et al. Prognostic value of serum tetranectin in patients with metastatic breast cancer. Acta Oncol. 1993;32(6):631–636.
  • Kamper EF, Kopeikina LT, Trontzas P, et al. Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis. Clin Rheumatol. 1998;17(4):318–324.
  • Kamper EF, Kopeikina LT, Koutsoukos V, et al. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis. J Rheumatol. 1997;24(2):262–268.
  • McDonald K, Glezeva N, Collier P, et al. Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis. Sci Rep. 2020;10(1):7507.
  • Murphy MS, Bytautiene E, Saade G, et al. Alterations to the maternal circulating proteome after preeclampsia. Am J Obstet Gynecol. 2015;213(6):853 e1–9.
  • Dai W, Wang Y, Yang T, et al. Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals. Cell Commun Signal. 2019;17(1):113.
  • Hogdall EV, Hogdall CK, Clemmensen I, et al. Tetranectin in amniotic fluid, maternal serum and fetal fluids. Scand J Clin Lab Invest. 1991;51(5):411–415.
  • Iba K, Sawada N, Chiba H, et al. Transforming growth factor-β1 downregulates dexamethasone-indunced tetranectin gene expression during the in vitro mineralization of the human osteoblastic cell line SV-HFO. FEBS Letters. 1995;373(1):1–4.
  • Adu-Gyamfi EA, Ding YB, Wang YX. Regulation of placentation by the transforming growth factor beta superfamily†. Biol Reprod. 2020;102(1):18–26.
  • Godkin JD, Doré JJ. Transforming growth factor beta and the endometrium. Rev Reprod. 1998;3(1):1–6.
  • Ni N, Li Q. TGFβ superfamily signaling and uterine decidualization. Reprod Biol Endocrinol. 2017;15(1):84.
  • Jehan F, Sazawal S, Baqui AH, et al. Multiomics characterization of preterm birth in low- and middle-income countries. JAMA Netw Open. 2020;3(12):e2029655–e2029655.